- Home
- LTRN vs TURN Comparison
LTRN vs TURN Comparison
Compare LTRN & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- TURN
- Stock Information
- Founded
- LTRN 2013
- TURN 1981
- Country
- LTRN United States
- TURN United States
- Employees
- LTRN N/A
- TURN N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- LTRN Health Care
- TURN Finance
- Exchange
- LTRN Nasdaq
- TURN Nasdaq
- Market Cap
- LTRN 36.0M
- TURN 39.9M
- IPO Year
- LTRN 2020
- TURN N/A
- Fundamental
- Price
- LTRN $3.34
- TURN $4.01
- Analyst Decision
- LTRN Strong Buy
- TURN
- Analyst Count
- LTRN 1
- TURN 0
- Target Price
- LTRN $25.00
- TURN N/A
- AVG Volume (30 Days)
- LTRN 51.0K
- TURN 19.3K
- Earning Date
- LTRN 08-07-2025
- TURN 01-01-0001
- Dividend Yield
- LTRN N/A
- TURN N/A
- EPS Growth
- LTRN N/A
- TURN N/A
- EPS
- LTRN N/A
- TURN N/A
- Revenue
- LTRN N/A
- TURN $194,813.00
- Revenue This Year
- LTRN N/A
- TURN N/A
- Revenue Next Year
- LTRN N/A
- TURN N/A
- P/E Ratio
- LTRN N/A
- TURN N/A
- Revenue Growth
- LTRN N/A
- TURN 254.25
- 52 Week Low
- LTRN $2.55
- TURN $3.12
- 52 Week High
- LTRN $6.12
- TURN $4.25
- Technical
- Relative Strength Index (RSI)
- LTRN 50.68
- TURN 55.65
- Support Level
- LTRN $3.09
- TURN $3.96
- Resistance Level
- LTRN $3.31
- TURN $4.03
- Average True Range (ATR)
- LTRN 0.16
- TURN 0.06
- MACD
- LTRN 0.02
- TURN 0.00
- Stochastic Oscillator
- LTRN 78.06
- TURN 83.33
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.